Drugs & Medicine Recalls

Pharmaceutical recall notices, chemical impurities, and biological contamination.

Showing 24 of 400 results
Pharmaceutical
FDA DrugsClass II

Vancomycin HCI, 1.25 grams added to 250 mL, 0.9% Sodium Chloride Injection USP, ...

Lack of Assurance of Sterility; blue Break-Off-Part could detach from the administration port

Apr 15, 2026Fagron Compounding Services
Pharmaceutical
FDA DrugsClass II

0.9% Sodium Chloride Injection, USP, 900 mg per 100 mL (9 mg per mL) 100 mL in a...

Lack of Assurance of Sterility

Apr 15, 2026Fresenius Kabi USA, LLC
Pharmaceutical
FDA DrugsClass II

Lanreotide Injection, 120 mg/0.5 mL, Box contains 1 Pre-filled syringe, Single d...

Lack of Assurance of Sterility: Due to an FDA observation at the contract manufacturing site for deficiencies in their visual inspection procedure.

Apr 15, 2026Cipla USA, Inc.
Pharmaceutical
FDA DrugsClass II

5% Dextrose Injection, USP 12.5 g per 250 mL (50 mg per mL) 250 mL in a 250 mL f...

Lack of Assurance of Sterility

Apr 15, 2026Fresenius Kabi USA, LLC
Pharmaceutical
FDA DrugsClass II

Artificial Tears Lubricant Eye Drops (glycerin 0.2%, hypromellose 0.2%, polyethy...

Lack of Assurance of Sterility

Apr 15, 2026Preferred Pharmaceuticals, Inc.
Pharmaceutical
FDA DrugsClass II

norepinephrine Bitartrate,16mg per 250mL 0.9% Sodium Chloride Injection USP, Fag...

Lack of Assurance of Sterility; blue Break-Off-Part could detach from the administration port

Apr 15, 2026Fagron Compounding Services
Pharmaceutical
FDA DrugsClass II

0.9% Sodium Chloride Injection, USP 0.9% (450 mg per 50 mL) (9 mg per mL) 50 mL,...

Lack of Assurance of Sterility

Apr 15, 2026Fresenius Kabi USA, LLC
Pharmaceutical
FDA DrugsClass II

0.9% Sodium Chloride Injection, USP, 50 mL x60, Becton, Dickson and Company, 1 B...

Lack of Assurance of Sterility

Apr 15, 2026Fresenius Kabi USA, LLC
Pharmaceutical
FDA DrugsClass II

Isotretinoin Capsules, USP, 40 mg, 10 count Prescription Pacs, Rx only, Manufact...

Superpotent and Subpotent

Apr 15, 2026Teva Pharmaceuticals USA, Inc
Pharmaceutical
FDA DrugsClass II

Isotretinoin Capsules, USP, 30 mg, Rx Only, 10 count Prescription Pack, Manufact...

Superpotent and Subpotent

Apr 15, 2026Teva Pharmaceuticals USA, Inc
Pharmaceutical
FDA DrugsClass II

0.9% Sodium Chloride Injection, USP, (2,250 mg per 250 mL) (9 mg per mL) 250 mL ...

Lack of Assurance of Sterility

Apr 15, 2026Fresenius Kabi USA, LLC
Pharmaceutical
FDA DrugsClass II

norepinephrine Bitartrate, 32mg per 250mL 0.9% Sodium Chloride Injection USP, Fa...

Lack of Assurance of Sterility; blue Break-Off-Part could detach from the administration port

Apr 15, 2026Fagron Compounding Services
Pharmaceutical
FDA DrugsClass II

0.9% Sodium Chloride Injection, USP, 900 mg per 100 mL (9 mg per mL) 1,000 mL in...

Lack of Assurance of Sterility

Apr 15, 2026Fresenius Kabi USA, LLC
Pharmaceutical
FDA DrugsClass II

0.9% Sodium Chloride Injection, USP, 900 mg per 100 mL (9 mg per mL) 250 mL in a...

Lack of Assurance of Sterility

Apr 15, 2026Fresenius Kabi USA, LLC
Pharmaceutical
FDA DrugsClass II

Vancomycin HCL, 1 gram added to 250 mL, 0.9% Sodium Chloride Injection USP, Fagr...

Lack of Assurance of Sterility; blue Break-Off-Part could detach from the administration port

Apr 15, 2026Fagron Compounding Services
Pharmaceutical
FDA DrugsClass II

Lanreotide Injection, 120 mg*/0.5 mL, Box contains 1 Pre-filled syringe and 1 sa...

Lack of Assurance of Sterility: Due to an FDA observation at the contract manufacturing site for deficiencies in their visual inspection procedure.

Apr 15, 2026Cipla USA, Inc.
Pharmaceutical
FDA DrugsClass II

0.45% Sodium Chloride Injection, USP, 1.125 grams per 250 mL (4.5 mg per mL), 25...

Lack of Assurance of Sterility

Apr 15, 2026Fresenius Kabi USA, LLC
Pharmaceutical
FDA DrugsClass II

Clonidine Transdermal System, USP, 0.2 mg/day, supplied in cartons of 4 Systems ...

CGMP Deviations: use of an unapproved raw material

Apr 15, 2026Teva Pharmaceuticals USA, Inc
Pharmaceutical
FDA DrugsClass II

0.9% Sodium Chloride Injection, USP 900 mg per 100 mL (9 mg per mL) 500 mL in a ...

Lack of Assurance of Sterility

Apr 15, 2026Fresenius Kabi USA, LLC
Pharmaceutical
FDA DrugsClass II

0.9% Sodium Chloride Injection, USP, 0.9% (900 mg per 100 mL) (9 mg per mL) 100 ...

Lack of Assurance of Sterility

Apr 15, 2026Fresenius Kabi USA, LLC
Pharmaceutical
FDA DrugsClass II

Clonidine Transdermal System, USP, 0.1 mg/day, supplied in cartons of 4 Systems ...

CGMP Deviations: use of an unapproved raw material

Apr 15, 2026Teva Pharmaceuticals USA, Inc
Pharmaceutical
FDA DrugsClass II

Clonidine Transdermal System, USP, 0.3 mg/day, supplied in cartons of 4 Systems ...

CGMP Deviations: use of an unapproved raw material

Apr 15, 2026Teva Pharmaceuticals USA, Inc
Pharmaceutical
FDA DrugsClass II

GE Healthcare Omnipaque (iohexol) Injection, 300 mg/mL (64.7%), Rx Only, Distrib...

Presence of particulate matter

Apr 15, 2026GE Healthcare Ireland Limited
Pharmaceutical
FDA DrugsClass II

GE Healthcare Omnipaque (iohexol) Injection, 350 mg/mL (64.7%), Rx Only, Distrib...

Presence of particulate matter

Apr 15, 2026GE Healthcare Ireland Limited